{"id":"cefacetrile","rwe":[],"tags":[{"label":"cefacetrile","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"J01DB10","category":"atc"},{"label":"Active","category":"status"},{"label":"Anti-Bacterial Agents","category":"pharmacology"},{"label":"Anti-Infective Agents","category":"pharmacology"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"cephacetril","offLabel":[],"synonyms":["cefacetrile sodium","cefacetrile","cephacetril","cephacetrile"],"timeline":[],"brandName":"Cephacetril","ecosystem":[],"mechanism":{"target":"Penicillin-binding protein 1A","modality":"Small Molecule","drugClass":"cefacetrile","explanation":"Imagine your body's cells are like houses, and the bacteria are like construction workers trying to build new houses. Cephacetril is like a construction foreman who stops the workers from building the houses by blocking the tools they need. This prevents the bacteria from growing and multiplying, helping to fight off the infection.","oneSentence":"Cephacetril works by blocking the enzymes that bacteria need to build their cell walls, ultimately leading to the death of the bacteria.","technicalDetail":"Cephacetril exerts its antibacterial effect by inhibiting the transpeptidase enzymes responsible for cross-linking peptidoglycan chains in the bacterial cell wall, ultimately leading to cell lysis and death."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/524","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=cefacetrile","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=cefacetrile","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:11:33.651822","biosimilars":[],"competitors":[{"drugName":"cefalexin","drugSlug":"cefalexin","fdaApproval":"1971-01-04","relationship":"same-class"},{"drugName":"cefalotin","drugSlug":"cefalotin","fdaApproval":"1974-12-18","relationship":"same-class"},{"drugName":"cefazolin","drugSlug":"cefazolin","fdaApproval":"1973-10-04","genericCount":20,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"cefadroxil","drugSlug":"cefadroxil","fdaApproval":"1978-02-17","genericCount":18,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"cefapirin","drugSlug":"cefapirin","fdaApproval":"1974-03-12","relationship":"same-class"},{"drugName":"cefradine","drugSlug":"cefradine","fdaApproval":"1974-08-19","relationship":"same-class"}],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"cefacetrile","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"cefalexin","brandName":"cefalexin","genericName":"cefalexin","approvalYear":"1971","relationship":"same-class"},{"drugId":"cefalotin","brandName":"cefalotin","genericName":"cefalotin","approvalYear":"1974","relationship":"same-class"},{"drugId":"cefazolin","brandName":"cefazolin","genericName":"cefazolin","approvalYear":"1973","relationship":"same-class"},{"drugId":"cefadroxil","brandName":"cefadroxil","genericName":"cefadroxil","approvalYear":"1978","relationship":"same-class"},{"drugId":"cefapirin","brandName":"cefapirin","genericName":"cefapirin","approvalYear":"1974","relationship":"same-class"},{"drugId":"cefradine","brandName":"cefradine","genericName":"cefradine","approvalYear":"1974","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07207876","phase":"","title":"Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy","status":"RECRUITING","sponsor":"International Maternal Pediatric Adolescent AIDS Clinical Trials Group","startDate":"2026-02-16","conditions":["Pregnancy"],"enrollment":110,"completionDate":"2027-05-17"},{"nctId":"NCT07484633","phase":"PHASE4","title":"A Randomised Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients.","status":"NOT_YET_RECRUITING","sponsor":"Semmelweis University","startDate":"2026-04","conditions":["Infection","Sepsis","NICU","PICU","Beta Lactams"],"enrollment":110,"completionDate":"2028-04"},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":["Mycobacterium Abscessus Pulmonary Disease","Mycobacterium Abscessus Infection","Non-Tuberculous Mycobacterial (NTM) Infections","Non-Tuberculous Mycobacteria Pulmonary Disease"],"enrollment":300,"completionDate":"2031-07"},{"nctId":"NCT06406114","phase":"PHASE2","title":"Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-05-05","conditions":["Drug Allergy","Cephalosporin Allergy","Drug Hypersensitivity","Antibiotic Allergy","Beta Lactam Adverse Reaction","Drug-Induced Anaphylaxis","Cephalosporin Reaction"],"enrollment":300,"completionDate":"2028-12-31"},{"nctId":"NCT06611111","phase":"EARLY_PHASE1","title":"Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease","status":"RECRUITING","sponsor":"State University of New York - Upstate Medical University","startDate":"2025-02-03","conditions":["Post-Treatment Lyme Disease"],"enrollment":44,"completionDate":"2026-12"},{"nctId":"NCT06712641","phase":"PHASE4","title":"Aminoglycosides in Early Sepsis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Akershus","startDate":"2026-04","conditions":["Sepsis"],"enrollment":1900,"completionDate":"2033-05"},{"nctId":"NCT06494072","phase":"PHASE4","title":"Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-08-22","conditions":["Community Acquired Pneumonia in Children"],"enrollment":236,"completionDate":"2028-05"},{"nctId":"NCT05294588","phase":"PHASE2","title":"Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-04-18","conditions":["Gonorrhea Male"],"enrollment":65,"completionDate":"2026-02-05"},{"nctId":"NCT05980871","phase":"PHASE4","title":"Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline","status":"TERMINATED","sponsor":"National Taiwan University Hospital","startDate":"2023-03-10","conditions":["Early Syphilis"],"enrollment":109,"completionDate":"2025-07-25"},{"nctId":"NCT06819592","phase":"PHASE3","title":"PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury","status":"RECRUITING","sponsor":"The George Institute","startDate":"2025-10-30","conditions":["All-cause Mortality","Quality of Life","Disability, Intellectual","Neurological Disorder","Acute Brain Injury","Ventilation, Mechanical","Intensive Care Medicine"],"enrollment":3300,"completionDate":"2029-12"},{"nctId":"NCT02701595","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":["Infective Endocarditis"],"enrollment":324,"completionDate":"2023-06-24"},{"nctId":"NCT05750966","phase":"NA","title":"Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2023-07-19","conditions":["Cholangitis"],"enrollment":440,"completionDate":"2026-09-01"},{"nctId":"NCT04986254","phase":"","title":"PNEUmonia DOSing in Critically Ill Patients (PNEUDOS)","status":"COMPLETED","sponsor":"The University of Queensland","startDate":"2019-10-17","conditions":["Pneumonia"],"enrollment":179,"completionDate":"2024-01-31"},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":["Preterm Premature Rupture of Membrane","Pregnancy, High Risk","Preterm Birth"],"enrollment":56,"completionDate":"2026-12"},{"nctId":"NCT04349826","phase":"PHASE4","title":"The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)","status":"COMPLETED","sponsor":"Oxford University Clinical Research Unit, Vietnam","startDate":"2021-05-23","conditions":["Typhoid Fever"],"enrollment":2150,"completionDate":"2025-12-31"},{"nctId":"NCT05079620","phase":"PHASE4","title":"Early Antibiotics After Aspiration in ICU Patients","status":"TERMINATED","sponsor":"UConn Health","startDate":"2021-11-30","conditions":["Aspiration","Aspiration Pneumonia"],"enrollment":5,"completionDate":"2024-04-12"},{"nctId":"NCT07308457","phase":"NA","title":"Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients","status":"RECRUITING","sponsor":"Pomeranian Medical University Szczecin","startDate":"2024-09-01","conditions":["Incidence of Infectious Diseases"],"enrollment":100,"completionDate":"2027-10-31"},{"nctId":"NCT03012360","phase":"PHASE4","title":"Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2018-02-08","conditions":["Mechanical Ventilation Complication","Critical Illness"],"enrollment":103,"completionDate":"2024-07-07"},{"nctId":"NCT02473263","phase":"PHASE3","title":"Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-05-09","conditions":["Severe Septic Syndrome (Severe Sepsis and Septic Shock) Diagnosed and Treated by Mobile Intensive Care Unit"],"enrollment":398,"completionDate":"2019-02-09"},{"nctId":"NCT07229755","phase":"PHASE2,PHASE3","title":"Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-07-01","conditions":["Urinary Tract Infection (Diagnosis)"],"enrollment":140,"completionDate":"2025-02-05"},{"nctId":"NCT03959527","phase":"PHASE3","title":"Zoliflodacin in Uncomplicated Gonorrhoea","status":"COMPLETED","sponsor":"Global Antibiotics Research and Development Partnership","startDate":"2019-11-06","conditions":["Gonorrhea"],"enrollment":1011,"completionDate":"2023-09-18"},{"nctId":"NCT03413384","phase":"PHASE2","title":"To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia","status":"ACTIVE_NOT_RECRUITING","sponsor":"BrainX Corporation","startDate":"2019-02-15","conditions":["Parkinson's Disease Dementia"],"enrollment":100,"completionDate":"2025-12-31"},{"nctId":"NCT03068741","phase":"PHASE4","title":"Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Damon Scales","startDate":"2020-03-23","conditions":["Severe Sepsis or Septic Shock"],"enrollment":2040,"completionDate":"2025-12"},{"nctId":"NCT05121974","phase":"PHASE2","title":"Tebipenem Trial in Children With Shigellosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2022-08-18","conditions":["Shigellosis"],"enrollment":132,"completionDate":"2026-08-17"},{"nctId":"NCT02996656","phase":"NA","title":"Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery","status":"RECRUITING","sponsor":"Université de Montréal","startDate":"2016-12","conditions":["Propionibacterium Infection"],"enrollment":88,"completionDate":"2026-12"},{"nctId":"NCT06423898","phase":"PHASE4","title":"Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.","status":"RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2024-10-09","conditions":["Endocarditis, Infective"],"enrollment":284,"completionDate":"2028-12-31"},{"nctId":"NCT05821478","phase":"PHASE3","title":"Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients","status":"RECRUITING","sponsor":"Institut Pasteur","startDate":"2025-05-22","conditions":["Hidradenitis Suppurativa"],"enrollment":92,"completionDate":"2028-02-27"},{"nctId":"NCT07043855","phase":"NA","title":"Duration of Perioperative Antibiotics in Pancreatoduodenectomy","status":"NOT_YET_RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-08","conditions":["Pancreatoduodenectomy","PPPD","Infectious Complications"],"enrollment":558,"completionDate":"2027-10"},{"nctId":"NCT04999592","phase":"PHASE2","title":"Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)","status":"TERMINATED","sponsor":"David J. Gagnon","startDate":"2021-08-20","conditions":["Out-Of-Hospital Cardiac Arrest","Pneumonia"],"enrollment":53,"completionDate":"2024-11-01"},{"nctId":"NCT06907316","phase":"PHASE4","title":"Cefixime Versus Benzathine Penicillin G in Treatment of Early Syphilis","status":"TERMINATED","sponsor":"Bulovka Hospital","startDate":"2021-07-13","conditions":["Syphilis"],"enrollment":61,"completionDate":"2024-08-01"},{"nctId":"NCT04975945","phase":"PHASE4","title":"Assessing Parenteral Antibiotics Versus Single-time Intra-operative Intra-dermal Antibiotic Administration for Prevention of SSI","status":"WITHDRAWN","sponsor":"The Grant Medical College & Sir J.J. Group of Hospitals","startDate":"2021-08","conditions":["Surgical Wound Infection","Surgical Site Infection"],"enrollment":0,"completionDate":"2022-01"},{"nctId":"NCT05470517","phase":"PHASE2","title":"Antibiotic Instillation in Appendicitis","status":"COMPLETED","sponsor":"Johns Hopkins All Children's Hospital","startDate":"2023-01-05","conditions":["Complicated Appendicitis","Acute Appendicitis"],"enrollment":190,"completionDate":"2024-03-20"},{"nctId":"NCT04958122","phase":"PHASE3","title":"Cefixime Clinical Trial","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2021-06-20","conditions":["Syphilis","Human Immunodeficiency Virus"],"enrollment":400,"completionDate":"2027-06-30"},{"nctId":"NCT06828952","phase":"","title":"Risk Factors of Failure of Conservative Treatment in Acute Non Complicated Appendicitis","status":"NOT_YET_RECRUITING","sponsor":"Ahmed Mohammed Hussein Sayed","startDate":"2025-06-22","conditions":["Conservative Management"],"enrollment":100,"completionDate":"2025-12-02"},{"nctId":"NCT06166381","phase":"NA","title":"Parenteral Versus Combined Parenteral With Vancomycin-soaked Graft in ACL Reconstruction","status":"RECRUITING","sponsor":"University of Duhok","startDate":"2024-01-25","conditions":["Infection, Bacterial"],"enrollment":288,"completionDate":"2025-02"},{"nctId":"NCT05849090","phase":"EARLY_PHASE1","title":"Vancomycin and Tobramycin Powder Use in Acute Open Fractures","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-03-27","conditions":["Infections"],"enrollment":10,"completionDate":"2024-12-12"},{"nctId":"NCT06616168","phase":"PHASE1","title":"Urogenital Infections in Women of Reproductive Age and the Activity of 4-Thiazolidinone Derivatives Against Pathogens","status":"ACTIVE_NOT_RECRUITING","sponsor":"Danylo Halytsky Lviv National Medical University","startDate":"2023-09-01","conditions":["Bacterial Vaginosis"],"enrollment":200,"completionDate":"2027-08-31"},{"nctId":"NCT06572761","phase":"PHASE3","title":"A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-09","conditions":["Previable Labour With Intact Membranes"],"enrollment":350,"completionDate":"2028-05"},{"nctId":"NCT05804123","phase":"NA","title":"LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media","status":"COMPLETED","sponsor":"Anabio R&D","startDate":"2021-10-28","conditions":["Upper Respiratory Tract Infections"],"enrollment":175,"completionDate":"2024-08-01"},{"nctId":"NCT05027516","phase":"PHASE4","title":"Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2022-01-17","conditions":["Neisseria Gonorrhoeae"],"enrollment":42,"completionDate":"2022-05-09"},{"nctId":"NCT06532409","phase":"NA","title":"Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone","status":"NOT_YET_RECRUITING","sponsor":"RESnTEC, Institute of Research","startDate":"2024-10-01","conditions":["Community-acquired Pneumonia"],"enrollment":114,"completionDate":"2025-09-30"},{"nctId":"NCT06527989","phase":"PHASE2,PHASE3","title":"Prophylactic Antibiotic in Subtalar Fusion Surgery","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-09-01","conditions":["Surgical Site Infection"],"enrollment":102,"completionDate":"2025-11-01"},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":["Community-acquired Pneumonia, Influenza, COVID-19"],"enrollment":20000,"completionDate":"2028-02"},{"nctId":"NCT04041791","phase":"PHASE3","title":"A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-08-19","conditions":["Pneumonia"],"enrollment":4392,"completionDate":"2024-04-05"},{"nctId":"NCT06454643","phase":"NA","title":"Gentamicin in Cardiac Surgery","status":"COMPLETED","sponsor":"Al-Rasheed University College","startDate":"2020-01-01","conditions":["Cardiac Infection"],"enrollment":50,"completionDate":"2021-01-01"},{"nctId":"NCT02784821","phase":"PHASE2","title":"Antibiotic \"Dysbiosis\" in Preterm Infants","status":"COMPLETED","sponsor":"University of Florida","startDate":"2017-01-16","conditions":["Enterocolitis, Necrotizing","Bacteremia","Bronchopulmonary Dysplasia","Intraventricular Hemorrhage","Periventricular Leukomalacia","Chronic Lung Disease","Ileal Perforation"],"enrollment":98,"completionDate":"2019-09-11"},{"nctId":"NCT04010539","phase":"PHASE3","title":"A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-10-21","conditions":["Gonorrhea"],"enrollment":628,"completionDate":"2023-10-10"},{"nctId":"NCT02424461","phase":"PHASE3","title":"Antibiotic Treatment for 7 Days Versus 14 Days in Patients With Acute Male Urinary Tract Infection","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-01-25","conditions":["Acute Male Urinary Tract Infection"],"enrollment":274,"completionDate":"2019-07-25"},{"nctId":"NCT06349122","phase":"PHASE4","title":"Screen-and-treat Strategy for Vaginal Flora Abnormalities in Pregnant Women at High Risk of Preterm Birth","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2024-08","conditions":["Bacterial Vaginosis","Vaginal Dysbiosis","Premature Delivery"],"enrollment":1292,"completionDate":"2028-01"},{"nctId":"NCT03681431","phase":"PHASE2","title":"Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2018-04-23","conditions":["Infectious Endocarditis"],"enrollment":12,"completionDate":"2019-05-23"},{"nctId":"NCT05761405","phase":"EARLY_PHASE1","title":"Potentiated Aminoglycosides in Postoperative Urinary Tract Infection Prophylaxis","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2024-01-16","conditions":["Urinary Tract Infections","Urological System Complication of Procedure"],"enrollment":90,"completionDate":"2026-04-15"},{"nctId":"NCT06220929","phase":"PHASE4","title":"Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury","status":"UNKNOWN","sponsor":"Sichuan Provincial People's Hospital","startDate":"2024-01-15","conditions":["Sepsis","Liver Dysfunction"],"enrollment":40,"completionDate":"2025-01-01"},{"nctId":"NCT05156437","phase":"PHASE4","title":"Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)","status":"ENROLLING_BY_INVITATION","sponsor":"Vinay Badhwar","startDate":"2022-03-16","conditions":["Endocarditis"],"enrollment":20,"completionDate":"2024-10"},{"nctId":"NCT05199324","phase":"PHASE4","title":"Early Oral Step-down Antibiotic Therapy for Uncomplicated Gram-negative Bacteraemia","status":"UNKNOWN","sponsor":"Tan Tock Seng Hospital","startDate":"2022-04-01","conditions":["Gram-negative Bacteraemia"],"enrollment":720,"completionDate":"2025-06-01"},{"nctId":"NCT03179384","phase":"PHASE4","title":"Impact on the Intestinal Microbiota of Treatment With Ceftriaxone in Women's Acute Community Pyelonephritis","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2017-06-26","conditions":["Pyelonephritis Acute"],"enrollment":9,"completionDate":"2019-02-05"},{"nctId":"NCT06090565","phase":"PHASE4","title":"Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea","status":"COMPLETED","sponsor":"Bulovka Hospital","startDate":"2021-04-01","conditions":["Gonorrhea"],"enrollment":161,"completionDate":"2022-12-22"},{"nctId":"NCT02021006","phase":"PHASE3","title":"Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract","status":"UNKNOWN","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2013-12","conditions":["Vesicoureteral Reflux","Renal Hypodysplasia, Nonsyndromic, 1","Chronic Kidney Disease"],"enrollment":292,"completionDate":"2025-01"},{"nctId":"NCT05149287","phase":"PHASE2","title":"PROPER Trial of Pain and Inflammation After Knee Arthroscopy","status":"TERMINATED","sponsor":"Austin V Stone","startDate":"2021-12-28","conditions":["Meniscus Tear","Meniscus Lesion","Cartilage Injury"],"enrollment":5,"completionDate":"2022-04-29"},{"nctId":"NCT02389036","phase":"PHASE3","title":"Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients","status":"COMPLETED","sponsor":"The George Institute","startDate":"2017-05-01","conditions":["Critical Illness","Sepsis","Septic Shock","Ventilator Associated Pneumonia"],"enrollment":20010,"completionDate":"2023-04-26"},{"nctId":"NCT05971550","phase":"PHASE3","title":"Clearance of Asymptomatic Pharyngeal Carriage of Neisseria Gonorrhoeae With or Without Ceftriaxone Treatment: Randomized Non-inferiority Study","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-09","conditions":["Neisseria Gonorrhoeae Infection","Asymptomatic Pharyngeal Carriage"],"enrollment":254,"completionDate":"2025-12"},{"nctId":"NCT05943223","phase":"PHASE2","title":"Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)","status":"UNKNOWN","sponsor":"McMaster Children's Hospital","startDate":"2024-01","conditions":["Appendicitis Perforated"],"enrollment":16,"completionDate":"2024-12"},{"nctId":"NCT05398081","phase":"PHASE2","title":"Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery","status":"COMPLETED","sponsor":"Dr. Promise Tamunoipiriala Jaja","startDate":"2021-12-01","conditions":["Surgical Site Infection","Antibiotics Prophylaxis"],"enrollment":96,"completionDate":"2022-03-05"},{"nctId":"NCT00138801","phase":"PHASE3","title":"Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis","status":"COMPLETED","sponsor":"Sorlandet Hospital HF","startDate":"2004-03","conditions":["Lyme Neuroborreliosis"],"enrollment":120,"completionDate":"2008-12"},{"nctId":"NCT02800785","phase":"NA","title":"The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial","status":"COMPLETED","sponsor":"University of Washington","startDate":"2016-05","conditions":["Appendicitis"],"enrollment":1552,"completionDate":"2021-09-01"},{"nctId":"NCT03087656","phase":"PHASE4","title":"Antibiotics to Decrease Post ERCP Cholangitis","status":"UNKNOWN","sponsor":"University of Southern California","startDate":"2017-03-29","conditions":["Cholangitis"],"enrollment":200,"completionDate":"2024-02-23"},{"nctId":"NCT04218695","phase":"PHASE4","title":"Prophylactic Antibiotics in Admitted Cirrhotics","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2020-08-24","conditions":["Cirrhosis, Liver"],"enrollment":32,"completionDate":"2021-08-28"},{"nctId":"NCT05654896","phase":"PHASE3","title":"Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Nadeem Iqbal","startDate":"2022-11-26","conditions":["Antibiotic Prophylaxis"],"enrollment":158,"completionDate":"2023-12-26"},{"nctId":"NCT03877289","phase":"PHASE4","title":"Efficacy of Oxybutynin in Paediatric Cystitis","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2008-10","conditions":["Cystitis"],"enrollment":81,"completionDate":"2014-07"},{"nctId":"NCT00591318","phase":"PHASE1,PHASE2","title":"A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis","status":"TERMINATED","sponsor":"Research Foundation for Mental Hygiene, Inc.","startDate":"2007-10-10","conditions":["Psychosis","Schizophrenia","Schizoaffective Disorder"],"enrollment":12,"completionDate":"2011-03-17"},{"nctId":"NCT02334124","phase":"NA","title":"Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2015-01","conditions":["Cellulitis"],"enrollment":190,"completionDate":"2022-11"},{"nctId":"NCT03660488","phase":"PHASE2","title":"Cefixime for Alternative Syphilis Treatment","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2018-09-03","conditions":["Syphilis","Early Syphilis"],"enrollment":58,"completionDate":"2021-01-30"},{"nctId":"NCT05427747","phase":"PHASE4","title":"Meropenem vs Cefotaxime as Empirical Treatment of SBP","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-01-01","conditions":["Spontaneous Bacterial Peritonitis"],"enrollment":286,"completionDate":"2024-02"},{"nctId":"NCT05027893","phase":"NA","title":"Complications After Lower Third Molar Surgery","status":"UNKNOWN","sponsor":"University of Novi Sad","startDate":"2019-06-07","conditions":["Postoperative Complications","Antibiotic Reaction","Antibiotic Side Effect","Antibiotic Resistant Infection","Antibiotic Resistant Strain","Infection, Bacterial","Infection, Laboratory"],"enrollment":157,"completionDate":"2023-12-31"},{"nctId":"NCT05417997","phase":"PHASE3","title":"Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients","status":"COMPLETED","sponsor":"RAAS Nutritionals, LLC","startDate":"2021-05-29","conditions":["COVID-19 Respiratory Infection","FLU","Cold; Influenza","Bacterial Pneumonia","COVID-19 Pneumonia"],"enrollment":71,"completionDate":"2021-12-02"},{"nctId":"NCT03440216","phase":"NA","title":"Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units","status":"UNKNOWN","sponsor":"Université Catholique de Louvain","startDate":"2018-03-15","conditions":["Pharmacokinetics","Anti-Bacterial Agents","Infection, Bacterial","Infections, Respiratory","Infection","Drug Monitoring"],"enrollment":20,"completionDate":"2022-12-15"},{"nctId":"NCT05375240","phase":"PHASE2","title":"Propranolol on Post Stroke Immune Status and Infection","status":"UNKNOWN","sponsor":"Tianjin Medical University General Hospital","startDate":"2022-06","conditions":["Stroke","Cerebrovascular Disorders","Ischemic Stroke","Brain Diseases","Central Nervous System Diseases","Nervous System Diseases","Cardiovascular Diseases","Propranolol","Beta Blocker","Molecular Mechanisms of Pharmacological Action","Immunologic Factors","Physiological Effects of Drugs"],"enrollment":45,"completionDate":"2024-06"},{"nctId":"NCT05216744","phase":"PHASE2","title":"Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia Coinfection","status":"COMPLETED","sponsor":"Haiphong University of Medicine and Pharmacy","startDate":"2021-07-15","conditions":["Neisseria Gonorrhoeae Infection","Chlamydia Trachomatis Infection"],"enrollment":125,"completionDate":"2022-02-20"},{"nctId":"NCT02596503","phase":"PHASE1","title":"A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2015-10-21","conditions":["Relapsed Solid Tumors","Refractory Solid Tumors"],"enrollment":2,"completionDate":"2020-01-24"},{"nctId":"NCT04870138","phase":"PHASE1","title":"Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2013-03-10","conditions":["Gonococcal Infection"],"enrollment":16,"completionDate":"2015-04-28"},{"nctId":"NCT00000648","phase":"NA","title":"A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":["HIV Infections","Neurosyphilis"],"enrollment":100,"completionDate":"1996-02"},{"nctId":"NCT05051163","phase":"PHASE2,PHASE3","title":"Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2021-06-14","conditions":["HIV-1-infection","Malnutrition, Child"],"enrollment":300,"completionDate":"2024-06-14"},{"nctId":"NCT03903783","phase":"NA","title":"Impact of Cefotaxime and Ceftriaxone on the Emergence and Carrying of Multidrug-Resistant Bacteria","status":"COMPLETED","sponsor":"Fondation Hôpital Saint-Joseph","startDate":"2019-04-30","conditions":["Infection, Bacterial"],"enrollment":34,"completionDate":"2021-08-13"},{"nctId":"NCT04982861","phase":"NA","title":"Bioequivalence Study of Cefixime Trihydrate Dry Syrup in Indonesia Healthy Volunteers","status":"COMPLETED","sponsor":"PT Bernofarm","startDate":"2020-06-15","conditions":["Drug Use"],"enrollment":22,"completionDate":"2020-08-25"},{"nctId":"NCT03294395","phase":"PHASE3","title":"New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea","status":"COMPLETED","sponsor":"Public Health Service of Amsterdam","startDate":"2017-09-18","conditions":["Gonorrhea"],"enrollment":346,"completionDate":"2020-06-05"},{"nctId":"NCT04839653","phase":"NA","title":"Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria","status":"UNKNOWN","sponsor":"MEDSI Clinical Hospital 1, ICU","startDate":"2021-05-01","conditions":["Pneumonia, Ventilator-Associated","Pneumonia","Bloodstream Infection","Sepsis","Respiratory Distress Syndrome","Respiratory Tract Infections","Critical Illness"],"enrollment":60,"completionDate":"2023-04"},{"nctId":"NCT04879030","phase":"PHASE2,PHASE3","title":"Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD","status":"COMPLETED","sponsor":"Haiphong University of Medicine and Pharmacy","startDate":"2020-01-01","conditions":["COPD Exacerbation Acute"],"enrollment":170,"completionDate":"2020-12-30"},{"nctId":"NCT03133637","phase":"","title":"Ceftriaxone and Jaundice in Neonates","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2016-03","conditions":["Jaundice and Sepsis in Neonates"],"enrollment":27,"completionDate":"2019-08-31"},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":["Osteomyelitis"],"enrollment":11,"completionDate":"2018-11-07"},{"nctId":"NCT03840811","phase":"PHASE1","title":"Experimental Human Infection With Neisseria Gonorrhoeae","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-04-23","conditions":["Gonococcal Infection"],"enrollment":27,"completionDate":"2019-11-25"},{"nctId":"NCT00462020","phase":"NA","title":"Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2007-03","conditions":["Perforated Appendicitis"],"enrollment":102,"completionDate":"2008-11"},{"nctId":"NCT00786669","phase":"PHASE1","title":"A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2008-10","conditions":["Solid Tumor"],"enrollment":13,"completionDate":"2012-11"},{"nctId":"NCT00161330","phase":"PHASE3","title":"Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT","status":"TERMINATED","sponsor":"University of Padova","startDate":"2000-06","conditions":["Urinary Tract Infections"],"enrollment":440,"completionDate":"2005-07"},{"nctId":"NCT03794765","phase":"PHASE2","title":"Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-04-01","conditions":["Ulcerative Colitis","Inflammatory Bowel Diseases","Acute Severe Colitis"],"enrollment":50,"completionDate":"2020-04-04"},{"nctId":"NCT03560232","phase":"PHASE4","title":"Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens","status":"TERMINATED","sponsor":"Mercy Health Ohio","startDate":"2018-07-09","conditions":["Open Fracture","Post-Op Wound Infection"],"enrollment":17,"completionDate":"2020-02-19"},{"nctId":"NCT01595529","phase":"PHASE2","title":"The SCOUT Study: \"Short Course Therapy for Urinary Tract Infections in Children\"","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-05-18","conditions":["Urinary Tract Infection"],"enrollment":717,"completionDate":"2019-08-12"},{"nctId":"NCT04461925","phase":"PHASE1,PHASE2","title":"Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs","status":"UNKNOWN","sponsor":"Institute of Cell Therapy","startDate":"2020-05-02","conditions":["COVID-19 Pneumonia"],"enrollment":30,"completionDate":"2021-12"},{"nctId":"NCT03174236","phase":"PHASE3","title":"First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2017-09-04","conditions":["Malnutrition Severe","Antibiotic Resistance","Antibiotic Toxicity"],"enrollment":2000,"completionDate":"2020-12-31"},{"nctId":"NCT01265173","phase":"PHASE4","title":"Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC","status":"COMPLETED","sponsor":"Korea University","startDate":"2007-04","conditions":["SBP","Liver Cirrhosis"],"enrollment":261,"completionDate":"2018-06"},{"nctId":"NCT00566111","phase":"NA","title":"Ceftriaxone in the Management of Bipolar Depression","status":"TERMINATED","sponsor":"Yale University","startDate":"2007-09","conditions":["Bipolar Depression"],"enrollment":5,"completionDate":"2009-12"},{"nctId":"NCT03752112","phase":"PHASE1,PHASE2","title":"Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women","status":"UNKNOWN","sponsor":"World Health Organization","startDate":"2019-11-22","conditions":["Syphilis Female"],"enrollment":180,"completionDate":"2021-09-30"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"NDDF":"005968","UNII":"FDM21QQ344","CHEBI":"CHEBI:31364","INN_ID":"3007","UMLSCUI":"C0007714","ChEMBL_ID":"CHEMBL2110602","KEGG_DRUG":"D01262","DRUGBANK_ID":"DB01414","PUBCHEM_CID":"91562","IUPHAR_LIGAND_ID":"12192","MESH_DESCRIPTOR_UI":"D002505"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"2.02 hours","clearance":"3.69 mL/min/kg","bioavailability":"0%","volumeOfDistribution":"0.49 L/kg"},"publicationCount":11,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"J01DB10","allCodes":["J01DB10"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Cephacetril, also known as cefacetrile, is a small molecule antibiotic in the cefacetrile class. Its mechanism of action involves inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. However, due to limited information, its target and approved indications are unknown. The commercial status of cephacetril is unclear, and it is not known if it is patented or available as a generic. Key safety considerations include its short half-life of 2.02 hours and negligible bioavailability of 0%.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}